NTRK Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets
Author(s) -
Elke Pfaff,
Tiphaine Adam de Beaumais,
Antonin Marchais,
Cornelis M. van Tilburg,
Mirjam Blattner-Johnson,
Uta Dirksen,
Ingrid Øra,
Birgit Geoerger,
Gudrun Schleiermacher,
Stefan M. Pfister,
Olaf Witt,
David Jones,
Gilles Vassal
Publication year - 2021
Publication title -
jco precision oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.20.00417
Subject(s) - drug , dna sequencing , medicine , gene , pharmacology , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom